Environmental antiandrogens: Developmental effects, molecular mechanisms, and clinical implications

Journal of Molecular Medicine

Volumn 75, Issue 3, 1997, Pages 198-207

  Kelce, William R ^a,b   Wilson, Elizabeth M ^b  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

1,1 Dichloro 2,2 bis(p chlorophenyl) ethylene; Androgen receptor; Antiandrogen; Breast cancer; Endocrine disruptor; Hypospadias; Sex differentiation; Vinclozolin

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHYLENE; ANTIANDROGEN; CHLORPHENOTANE; FLUTAMIDE; HYDROXYFLUTAMIDE; VINCLOZOLIN;

BREAST CANCER; ENVIRONMENT; HUMAN; MALE GENITAL TRACT MALFORMATION; MALE INFERTILITY; REPRODUCTION; REVIEW; SABAL; SEX DIFFERENTIATION;

EID: 0030981923     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090050104     Document Type: Review

References (110)

1. Hose JE, Guillette LJ (1995) Defining the role of pollutants in the disruption of reproduction in wildlife. Environ Health Perspect [Suppl 4]103:87-91
2. Kelce WR, Stone CS, Laws SC, Gray LE, Kemppainen JA, Wilson EM (1995) Persistent DDT metabolite, p,p′-DDE is a potent undrogen receptor antagonist. Nature 375:581-585
3. Eil C, Nisula BC (1990) The binding properties of pyrethroids to human skin fibroblast androgen receptors and to sex hormone binding globulin. J Steroid Biochem 35:409-414
4. Hosokawa S, Murakami M, Ineyama M, Yamada T, Yoshitake A, Yamada H, Miyamoto J (1993) The affinity of procymidone to androgen receptor in rats and mice. J Toxicol Sci 18:83-93
5. Zhou Z-X, Lane MV, Kemppainen JA, French PS, Wilson EM (1995) Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability. Mol Endocrinol 9:208-218
6. Quigley CA, De Bellis A, Marschke KB, El-Awady MK, Wilson EM, French FS (1995) Androgen receptor defects: Historical, clinical and molecular perspectives. Endocr Rev 16:271-321
7. Langley E, Zhou Z-X, Wilson EM (1995) Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer. J Biol Chem 270:29983-29990
8. Housley PR, Sanchez ER, Danielson M, Ringold GM, Pratt WB (1990) Evidence that the conserved region in the steroid binding domain of the glucocorticoid receptor is required for both optimal binding of hsp90 and protection from proteolytic cleavage. A two site model for hsp90 binding to the steroid binding domain. J Biol Chem 265:12778-12781
9. Smith DF, Toft DO (1993) Steroid receptors and their associated proteins. Mol Endocrinol 7:4-11
10. Carson-Jurica MA, Schrader WT, O'Malley BW (1990) Steroid receptor family: structure and functions. Endocr Rev 11: 201-220
11. Baulieu EE (1989) Contragestion and other clinical applications of RU486, an antiprogesterone at the receptor. Science 245:1351-1357
12. Eckert RL, Katzenellenbogen BS (1982) Physical properties of estrogen receptor complexes in MCF-7 human breast cancer cells. J Biol Chem 257:8840-8846
13. Hansen JC, Gorski J 1986 Conformational transitions of the estrogen receptor monomer. J Biol Chem 261:13990-13996
14. Martin PM, Berthois Y, Jensen EV 1988 Binding of antiestrogens exposes an occult antigenic determinant in the human estrogen receptor. Proc Natl Acad Sci USA 85:2533-2537
15. Kuil CW, Mulder E (1994) Mechanism of antiandrogen action: conformational changes of the receptor. Mol Cell Endocrinol 102:R1-R5
16. Kuil CW, Berrevoets CA, Mulder E (1995) Ligand-induced conformational alterations of the androgen receptor analyzed by limited trypsinization. J Biol Chem 270:27569-27576
17. Gronemeyer H, Benhamou B, Berry M, Bocquel MT, Gofflo D, Garcia T, Lerouge T, Metzger D, Meyer ME, Tora L, Vergezac A, Chambon P (1992) Mechanisms of antihormone action. J Steroid Biochem Mol Biol 41:217-221
18. McDonnell DP, Clemm DL, Imhof MO (1994) Definition of the cellular mechanisms which distinguish between hormone and antihormone activated steroid receptors. Cancer Biol 5: 327-336
19. Allan GF, Tsai SY, Tsai M-J, O'Malley BW (1992a) Ligand-dependent conformational changes in the progesterone receptor are necessary for events that follow DNA binding. Proc Nat Acad Sci USA 89:11750-11754
20. Allan GF, Leng X, Tsai SY, Weigel NL, Edwards DP, Tsai M-J, O'Malley BW (1992b) Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation. J Biol Chem 267:19513-19520
21. Harris SE, Sarris MA, Rong Z, Hall J, Judge S, French FS, Joseph DR, Luhahn DB, Simental JA, Wilson EM (1991) Androgen regulation of HBGFI-(aFGF) and characterization of the androgen receptor mRNA in the human prostate carcinoma cell line LNCaP/A-dep. In: Karr JP, Coffey DS, Smith RG, Tindall DJ (eds) Molecular and cellular biology of prostate cancer. Plenum, New York, pp 315-330
22. Veldscholte J, Berrevoets CA, Ris-Stalpers C, Kuiper GGJM, Jenster G, Trapman J, Brinkman AO, Mulder E (1992) The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens. J Steroid Biochem Mol Biol 41:665-669
23. Veldscholte J, Berrevoets CA, Brinkman AO, Grootegoed JA, Mulder E (1992) Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding activity, heat-shock protein interaction, and transcription activation. Biochemistry 31:2393-2399
24. Horoszewisc JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Ming Chu T, Mirand EA, Murphy GP (1983) LNCaP model of human prostate carcinoma. Cancer Res 43:1809-1818
25. Schulz P, Bauer HW, Fittler F (1985) Steroid hormone regulation of prostatic acid phosphatase expression in cultured human prostate carcinoma cells. Biol Chem Hoppe-Seyler 366:1033-1039
26. Schuurmans ALG, Bolt J, Voorhorst MM, Blankenstein RA, Mulder E (1988) Regulation of growth and epidermal growth factor receptor levels of prostate tumor cells by different steroids. Int J Cancer 42:917-922
27. Kemppainen JA, Lane MV, Sar M, Wilson EM (1992) Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. J Biol Chem 267:968-974
28. Wilding G, Chen M, Gelman EP (1989) Aberrant response in vitro of hormone-responsive prostate cancer cells to antiandrogens. Prostate 14:103-115
29. Schuurmans ALG, Bolt J, Veldscholte J, Mulder E (1990) Stimulatory effects of antiandrogens on LNCaP human prostate tumor cell growth, EGF-receptor level and acid phosphatase secretion. J Steroid Biochem Mol Biol 37:848-853
30. Berns EMJJ, de Boer W, Mulder E (1986) Androgen-dependent growth regulation and release of specific proteins by the androgen receptor containing human prostate tumor cell line LNCaP. Prostate 9:247-259
31. Danielian PSA, White R, Hoare SA, Fawell SE, Parker MG (1993) Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen. Mol Endocrinol 7:232-240
32. Wrenn CK, Katzenellenbogen BS (1993) Structure-function analysis of the hormone binding domain of the human estrogen receptor by region-specific mutagenesis and phenotypic screening in yeast. J Biol Chem 268:24089-24098
33. Benhamou B, Garcia T, Lerouge T, Vergezac A, Gofflo D, Bigogne C, Chambon P, Gronemeyer H (1992) A single amino acid that determines the sensitivity of progesterone receptors to RU486. Science 255:206-209
34. Truss M, Bartsch J, Beato M (1994) Antiprogestins prevent progesterone recptor binding to hormone responsive elements in vivo. Proc Nat Acad Sci USA 91:11333-11337
35. El Ashry D, Onate SA, Nordeen SK, Edwards DP 1989 Human progesterone receptor complexed with the antagonist RU486 binds to hormone response elements in a structurally altered form. Mol Endocrinol 3:1545-1558
36. Guiochon-Mantel A, Loosfelt H, Ragot T, Bailly A, Atger M, Misrahi M, Perricaudet M, Milgrom E (1988) Receptors bound to antiprogestin form abortive complexes with hormone responsive elements. Nature 336:695-698
37. Meyer ME, Pornon A, Ji J, Bocquel MT, Chambon P, Gronemeyer H (1990) Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor. EMBO J 9:3923-3932
38. Wong, CI, Kelce WR, Sar M, Wilson EM (1995) Androgen receptor antagonist versus agonist activities of the fungicide vinclozolin relative to hydroxyflutamide. J Biol Chem 270: 19998-20003
39. Wilson JD (1978) Sexual differentiation. Ann Rev Physiol 40: 279-306
40. George FW, Wilson JD (1988) Sex determination and differentiation. In: Knobil E, Neill J (eds) The physiology of reproduction. Raven, New York
41. Mizokami A, Chang C (1994) Induction of translation by the 5′-untranslated region of human androgen receptor mRNA. J Biol Chem 269:25655-25659
42. Lubahn DB, Joseph DR, Sullivan PM, Willard HF, French FS, Wilson EM (1988) Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science 240:327-330
43. Brown CJ, Goss SJ, Lubahn DB, Joseph DR, Wilson EM, French FS, Willard HF (1989) Androgen receptor locus on the human X chromosome: regional localization to Xq 11-12 and description of a genetic polymorphism. Am J Hum Genet 44:264-269
44. Mahtani MM, Lafrenier RG, Kruse TA, Willard HF (1991) An 18-locus linkage map of the pericentromeric region of the human X chromosome: genetic framework for mapping X-linked disorders. Genomics 10:849-857
45. Wilson CM, Griffin JE, Wilson JD, Marcelli M, Zoppi S, McPhaul MJ (1992) Immunoreactive androgen receptor expression in subjects with androgen resistance. J Clin Endocrinol Metab 75:1474-1478
46. Quarmby VE, Kemppainen JA, Sar M, Lubahn DB, French FS, Wilson EM (1990) Expression of recombinant androgen receptor in cultured mammalian cells. Mol Endocrinol 4: 1399-1407
47. Jenster G, van der Korput HAGM, van Vroonhoven C, van der Kwast TH, Trapman J, Brinkman AO (1991) Domains of the human androgen receptor involved in steroid binding, transcriptional activation and subcellular localization. Mol Endocrinol 5:1396-1404
48. Lubahn DB, Joseph DR, Sar M, Tan J-A, Higgs HN, Larson RE, French FS, Wilson EM (1988) The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. Mol Endocrinol 2:1265-1275
49. Chang C, Kokontis J, Liao S (1988) Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors. Proc Nat Acad Sci USA 85:7211-7215
50. Trapman J, Klaassen P, Kuiper GGJM, van der Korput JAGM, Faber PW, van Rooij HCJ, Geurts van Kessel A, Voorhorst MM, Mulder E, Brinkmann AO (1988) Cloning, structure, and expression of a cDNA encoding the human androgen receptor. Biochem Biophys Res Commun 153:241-248
51. Tilley WD, Marcelli M, Wilson JD, McPhaul MJ (1989) Characterization and expression of a cDNA encoding the human androgen receptor. Proc Nat Acad Sci USA 86:327-331
52. Lubahn DB, Brown TR, Simental JA, Higgs HN, Migeon CJ, Wilson EM, French FS (1989) Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity. Proc Nat Acad Sci USA 86: 9534-9538
53. Bentvelsen FM, McPhaul MJ, Wilson JD, George FW (1994) The androgen receptor of the urogenital tract of the fetal rat is regulated by androgen. Mol Cell Endocrinol 105:21-26
54. Kelce WR, Monosson E, Gamcsik MP, Laws SC, Gray LE Jr (1994) Environmental hormone disruptors: evidence that vinclozolin developmental toxicity is mediated by antiandrogenic metabolites. Toxicol Appl Pharmacol 126:276-285
55. Gray LE Jr, Ostby JS, Kelce WR (1994) Developmental effects of an environmental antiandrogen: the fungicide vinclozolin alters sex differentiation of the male rat. Toxicol Appl Pharmacol 129:46-52
56. Fail PA, Pearce SW, Anderson SA, Tyl RW, Gray LE (1995) Endocrine and reproductive toxicity of vinclozolin (vin) in male Long-Evans Hooded rats. Fund Appl Toxicol 15:293
57. Edwards DP, Altman M, DeMarzo A, Zhang Y, Weigel NL, Beck CA (1995) Progesterone receptor and the mechanism of action of progesterone antagonists. J Steroid Biochem Mol Biol 53:449-458
58. Szokolay A, Rosival L, Uhnak J, Madaric A (1977) Dynamics of benzene hexachloride (BHC) isomers and other chlorinated pesticides in the food chain and in human fat. Ecotoxicol Environ Safety 1:349-359
59. Spindler M (1983) DDT: Health aspects in relation to man and risk/benefit assessment based thereupon. Residue Rev 90:1-34
60. Wyllie J, Gabica J, Benson WW (1972) Comparative organochlorine pesticide residues in serum and biopsied lipoid tissue: a survey of 200 persons in southern Idaho-1970. Pesticide Monitor J 6:84-88
61. Barquet A, Morgade C, Pfaffenberger CD (1981) Determination of organochlorine pesticides and metabolites in drinking water, human blood serum, and adipose tissue. J Toxicol Environ Health 7:469-479
62. Adamovic VM, Sokic B, Smiljanski M-J (1978) Some observations concerning the ratio of the intake of organochlorine insecticides through the food and amounts excreted in the milk of breast-feeding mothers. Bull Environ Contam Toxicol 20:280-285
63. O'Leary JA, Davies JE, Edmundson WF, Reich GA (1970) Transplacental passage of pesticides. Am J Obstet Gynecol 107:65-68
64. Rogan WJ, Gladen BC, McKinney JD, Carreras N, Hardy P, Thullen J, Tingelstad J, Tully M (1986) Polychlorinated biphenyls (PCB's) and dichlorodiphenyl dichloroethane (DDE) in human milk: effects of maternal factors and previous lactation. Am J Public Health 76:172-177
65. Imperato-McGinley J, Sanchez RS, Spencer JR, Yee B, Vaugan ED (1992) Comparison of the effects of the 5alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose response studies. Endocrinology 131:1149-1156
66. Simonich SL, Hites RA (1995) Global distribution of persistent organochlorine compounds. Science 269:1851-1854
67. Bouwman H, Cooppan RM, Becker PJ, Ngxongo S (1991) Malaria control and levels of DDT in serum of two populations in Kwazulu. J Toxicol Environ Health 33:141-155
68. Bouwman H, Reinecke AJ, Cooppan RM, Becker PJ (1990) Factors affecting levels of DDT and metabolites in human breast milk from Kwazulu. J Toxicol Environ Health 31:93-115
69. Curley A, Copeland MF, Kimbrough RD (1969) Chlorinated hydrocarbon insecticides in organs of stillborn and blood of newborn babies. Arch Environ Health 19:628-632
70. Carilla E, Briley M, Fauran F, Sultan CH, Duvilliers C (1984) Binding of permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostate. J Steroid Biochem Mol Biol 20:521-523
71. Champault G, Patel JC, Bonnard AM (1984) A double-blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia. Br J Clin Pharmacol 18:461-462
72. Jirasek JE (1971) In: Cohen MM (ed) Development of the genital system and male pseudohermaphroditism. Johns Hopkins University Press, Baltimore
73. Leung TJ, Baird PA, McGillivray B (1985) Hypospadias in British Columbia. Am J Med Genetics 21:39-48
74. Sweet RA, Schrott HG, Kurland R, Culp OS (1974) Study of the incidence of hypospadias in Rochester, Minn, 1940-1970, and a case-control comparision of possible etiologic factors. Mayo Clin Proc 49:52-58
75. Kalloo NB, Gearhart JP, Barrack ER (1993) Sexually dimorphic expression of estrogen receptors, but not of androgen receptors in human fetal external genetalia. J Clin Endocrinol Metab 77:692-698
76. Schardein J (1993) Hormones and hormone antagonists. In: Chemically induced birth defects, 2nd edn, chap. 9. Dekker, New York, pp 271-339
77. Allera A, Herbst MA, Griffin JE, Wilson JD, Schweikert H-U, McPhaul MJ (1995) Mutations of the androgen receptor coding sequence are infrequent in patients with isolated hypospadias. J Clin Endocrinol Metab 80:2697-2699
78. Hiort O, Klauber G, Cendron M, Sinnecker GGH, Keim L, Schwinger E, Wolfe HJ, Yandell DW (1994) Molecular characterization of the androgen receptor gene in boys with hypospadias. Eur J Pediatr 153:317-321
79. Wilson JD, Griffin JE, Russell DW (1993) Steroid 5-reductase 2 deficiency. Endocr Rev 14:577-593
80. Bentvelsen FM, Brinkmann AO, van der Linden JETM, Schroder FH, Nijman JM (1995) Decreased immunoreactive androgen receptor levels are not the cause of isolated hypospadias. Br J Urol 76:384-388
81. Henderson BE, Benton B, Cogsgrove M, Baptista J, Aldrich J, Townsend D, Hart W, Mack TM (1976) Urogenital tract abnormalities in sons of women treated with diethylstilboestrol. Pediatrics 58:505-507
82. Wilson EM, French FS (1976) Binding properties of androgen receptors. Evidence for identical receptors in rat testis, epididymis and prostate. J Biol Chem 25:5620-5629
83. Lobaccaro JM, Lumbroso S, Belon C, Galtier-Dereure F, Bringer J, Lesimple T, Heron JF, Pujol H, Sultan C (1993) Male breast cancer and the androgen receptor gene. Nature Genet 5:109-110
84. Wooster R, Mangion J, Eeles R, Smith S, Dowsed M, Averill D, Barrett-Lee P, Easton DF, Ponder BA, Stratum MR (1992) A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nature Genet 2:132-134
85. Lea OA, Kvinnsland S, Thorsen T (1989) Improved measurement of androgen receptors in human breast cancer. Cancer Res 49:7162-7168
86. Tormey DC, Lippman ME, Edwards BK, Cassidy JG (1983) Evaluation of tamoxifen doses wilh and without fluoxymesterone in advanced breast cancer. Ann Internal Med 98:139-144
87. Thomas BS, Bulbrook RD, Hayward JL, Millis RR (1982) Urinary androgen metabolites and recurrence rates in early breast cancer. Eur J Cancer Clin Oncol 18:447-451
88. Couture P, Theriault C, Simard J, Labrie F (1993) Androgen receptor mediated stimulation of 17b-hydroxysteroid dehydrogenase activity by dihydrotestosterone and medroxyprogesterone acetate in ZR-75-1 human breast cancer cells. Endocrinology 132:179-185
89. Poulin R, Simard J, Labrie C, Petitclerc L, Dumont M, Lagace L, Labrie F (1989) Down regulation of estrogen receptors by androgens in the ZR-75-1 human breast cancer cell line. Endocrinology 125:392-399
90. MacIndoe JH, Etre LA (1981) An antiestrogenic action of androgens in human breast cancer cells. J Clin Endocrinol Metab 53:836-842
91. Hackenberg R, Luttchens S, Hofmann J, Kunzmann R, Holzel F, Schulz KD (1991) Androgen sensitivity of the new human breast cancer cell line MFM-223. Cancer Res 51:5722-5727
92. Falck F, Ricci A, Wolff MS, Godbold J, Deckers P (1992) Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. Arch Environ Health 47:143-146
93. Wolff MS, Toniolo PG, Lee EW, Rivera M, Dubin N (1993) Blood levels of organochlorine residues and risk of breast cancer. J Natl Can Inst 85:648-652
94. Henderson AK, Rosen D, Miller GL, Figgs LW, Zahm SH, Sieber SM, Humphrey HEB, Sinks T (1995) Breast cancer among women exposed to polybrominated biphenyls. Epidemiology 6:544-546
95. Austin H, Keil JE, Cole P (1989) A prospective follow-up of cancer mortality in relation to serum DDT. Am J Public Health 79:43-46
96. Mussalo-Pauhamaa H, Hasanen E, Pyysalo H, Antervo K, Kauppila R, Pantzar P (1990) Occurrence of beta-hexachlorocyclohexane in breast cancer patients. Cancer 16:2124-2128
97. Nelson CMK, Bunge RG (1974) Semen analysis: evidence for changing parameters of male fertility potential. Fertil Steril 25:503-50
98. Leto S, Frensilli FJ (1981) Changing parameters of donor semen. Fertil Steril 36:766-770
99. Bostofte E, Serup J, Rebbe H (1983) Has the fertility of Danish men declined through the years in terms of semen quality? A comparison of semen qualities between 1952 and 1972. Int J Fertil 28:91-95
100. Carlsen E, Giwercman A, Keiding N, Skakkebaek NE (1992) Evidence for decreasing quality of semen during the past 50 years. BMJ 305:609-613
101. Skakkebaek NE, Keiding N (1994) Changes in semen and the testis. BMJ 309:1316-1317
102. Auger J, Kunstmann JM, Czyglik F, Jouannet P (1995) Decline in semen quality among fertile men in Paris during the past 20 years. New Engl J Med 332:281-285
103. Roberts KP, Zirkin BR (1991) Androgen regulation of spermatogenesis in the rat. Ann NY Acad Sci 637:90-106
104. Fisch H, Goluboff ET, Olson JH, Feldshuh J, Broder SJ, Barad DH (1996) Semen analysis in 1,283 men from the United States over a 25-year period: no decline in quality. Fertil Steril 65:1009-1014
105. Paulsen CA, Berman NG, Wang C (1996) Data from men in greater seattle area reveals no downward trend in semen quality: further evidence that deterioration of semen quality is not geographically uniform. Fertil Steril 65:1015-1020
106. Palmer T (1981) Regulatory requirements for reproductive toxicology: theory and practice. In: C Kimmel, J Buelke-Sam (Ed) Developmental toxicology. Raven, New York, pp 259-288
107. Makris S (1995) Proposed revisions to the testing guidelines for developmental toxicity and two-generation reproductive toxicity studies conducted under FIFRA and TSCA - A progress update. Toxicologist 15:287
108. Gray LE Jr, Ostby J, Sigmonn R, Ferrell J, Rehnberg G, Linder R, Cooper R, Goldman J, Laskey J (1988) The development of a protocol to assess reproductive effects of toxicants in the rat. Reprod Toxicol 2:281-287
109. Zenick H, Clegg ED, Perreault SD, Klinefelter GR, Gray LE (1994) Assessment of male reproductive toxicity: a risk assessment approach. In: Hayes AW (ed) Principle and methods of toxicology, 3rd edn. Raven, New York, pp 937-988
110. Waller CL, Juma BW, Gray LE, Kelce WR (1996) Three-dimensional quantitative structure activity relationships for androgen receptor ligands. Toxicol Appl Pharmacol 137:219-227